Market cap data unavailable. We couldn't positively verify this ticker's market cap is under $500M. Verify independently before trading.
Guided Therapeutics, Inc.
- Market Cap
- Unavailable
- Price
- $0.27
- % Change (Daily % change from the live per-ticker quote feed.)
- 0.00%
- Volume
- 111
About
Guided Therapeutics, Inc. is a medical technology firm specializing in the creation of medical devices. Its primary focus is on bringing to market LuViva, an innovative device designed for the non-invasive detection of cervical cancer. This technology excels at identifying both cancerous and precancerous conditions of the cervix in a painless, non-invasive manner, directly at the point of care. LuViva operates by scanning the cervix with light and subsequently analyzing both the reflected and fluorescent light emitted. Established in 1992 and headquartered in Norcross, Georgia, the company was formerly known as SpectRx, Inc. until its rebranding to Guided Therapeutics, Inc. in February 2008.
Quick stats
Shares outstanding—
Computed float31.3M
Float / sharesUnknown
Key info
SectorHealthcare
IndustryMedical - Devices
CIK (Central Index Key — the unique ID the SEC assigns to every filer. Use it to look up the company's filings on EDGAR.)0000924515
Websitehttps://www.guidedinc.com
AI Summary
AI-generated1/7
minorbullishoperations update
Guided Therapeutics Receives $80,000 Payment as Fourth Installment of $700,000 Purchase Order with Chinese Distributor
Guided Therapeutics received an $80,000 payment from Hangzhou Dongye Medical Technology, representing the fourth installment of a $700,000 purchase order.
Four LuViva Advanced Cervical Scan devices are expected to ship later this year, bringing the total shipped to eleven of 35 units scheduled for delivery over the next several months.
The company also highlighted a recent agreement with Yuanshuo Medical Instruments for 50 devices and 500,000 components pending NMPA approval.